Boundless Bio BOLD
NASDAQ BOLD
$2.56 -0.05 (-1.92%)
At close: Sep 29, 2026 · 4:00 PM EDT

Boundless Bio (BOLD) Enterprise Value (2024 - 2026)

Updated

Boundless Bio (BOLD) recorded Enterprise Value of -$16.41 million in Q2 2026, compared with -$104.49 million a year earlier.

Analysis

Boundless Bio (BOLD) Enterprise Value (2024 - 2026) Analysis & Trends

For FY2025, Boundless Bio reported Enterprise Value of -$80.71 million.

  • Across earlier years, Enterprise Value came in at -$102.85 million in FY2024.
  • The Q2 2026 figure is the highest quarterly Enterprise Value in data going back to Q1 2024.
  • Per Business Quant, the preceding three quarters came in at -$68.15 million (Q1 2026), -$80.71 million (Q4 2025) and -$90.07 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Boundless Bio 58.66 Mn 58.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -16.41 Mn
Mar 31, 2026 -68.15 Mn
Dec 31, 2025 -80.71 Mn
Sep 30, 2025 -90.07 Mn
Jun 30, 2025 -104.49 Mn
Mar 31, 2025 -104.63 Mn
Dec 31, 2024 -102.85 Mn
Sep 30, 2024 -89.88 Mn
Jun 30, 2024 -93.18 Mn
Mar 31, 2024 -86.97 Mn
API Access

Boundless Bio Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=BOLD&period=max&api_key=YOUR_API_KEY